EP1430112A4 - Nouveaux acides nucleiques et polypeptides - Google Patents

Nouveaux acides nucleiques et polypeptides

Info

Publication number
EP1430112A4
EP1430112A4 EP02780359A EP02780359A EP1430112A4 EP 1430112 A4 EP1430112 A4 EP 1430112A4 EP 02780359 A EP02780359 A EP 02780359A EP 02780359 A EP02780359 A EP 02780359A EP 1430112 A4 EP1430112 A4 EP 1430112A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
novel nucleic
novel
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02780359A
Other languages
German (de)
English (en)
Other versions
EP1430112A2 (fr
Inventor
Tom Y Tang
Jie Zhang
Feiyan Ren
Aidong J Xue
Qing A Zhao
Jian-Rui Wang
Tom Wehrman
Ping Zhou
Malabika Ghosh
Dunrui Wang
Yunqing Ma
Vinod Asundi
Zhiwei Wang
Gezhi Weng
Dana Haley-Vicente
Rodoje T Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1430112A2 publication Critical patent/EP1430112A2/fr
Publication of EP1430112A4 publication Critical patent/EP1430112A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP02780359A 2001-09-24 2002-09-24 Nouveaux acides nucleiques et polypeptides Withdrawn EP1430112A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32463101P 2001-09-24 2001-09-24
US324631P 2001-09-24
PCT/US2002/030474 WO2003029271A2 (fr) 2001-09-24 2002-09-24 Nouveaux acides nucleiques et polypeptides

Publications (2)

Publication Number Publication Date
EP1430112A2 EP1430112A2 (fr) 2004-06-23
EP1430112A4 true EP1430112A4 (fr) 2005-06-15

Family

ID=23264420

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02780359A Withdrawn EP1430112A4 (fr) 2001-09-24 2002-09-24 Nouveaux acides nucleiques et polypeptides

Country Status (4)

Country Link
EP (1) EP1430112A4 (fr)
AU (1) AU2002343417A1 (fr)
CA (1) CA2461280A1 (fr)
WO (1) WO2003029271A2 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2395524T3 (es) 2000-08-22 2013-02-13 Agensys, Inc. Acido nucleico y proteina correspondiente denominada 158P1D7 util para el tratamiento y la detección del cancer de vejiga y otros canceres
US7358353B2 (en) 2000-08-22 2008-04-15 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
US6979564B2 (en) 2000-10-20 2005-12-27 Millennium Pharmaceuticals, Inc. 80090, human fucosyltransferase nucleic acid molecules and uses thereof
US7309760B2 (en) * 2001-04-17 2007-12-18 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
WO2002083866A2 (fr) * 2001-04-17 2002-10-24 The Board Of Trustees Of The University Of Arkansas Sequences repetees du gene ca125 et leurs utilisations dans des interventions diagnostiques et therapeutiques
FR2836687A1 (fr) * 2002-03-04 2003-09-05 Gene Signal Genes impliques dans la regulation de l'angiogenese, preparations pharmaceutiques les contenant et leurs applications
JP2007504842A (ja) * 2003-05-29 2007-03-08 ミレニアム ファーマシューティカルズ， インコーポレイテッド 乳癌の同定、評価、予防、および治療のための組成物、キットおよび方法
GB0326197D0 (en) * 2003-11-10 2003-12-17 Randox Lab Ltd Molecular marker
US20090253770A1 (en) * 2004-05-18 2009-10-08 Kurume University Target gene mimitin of myc
WO2006035741A1 (fr) 2004-09-29 2006-04-06 Dainippon Sumitomo Pharma Co., Ltd. Gène exprimé spécifiquement dans les cellules es et utilisation dudit gène
GB0526212D0 (en) * 2005-12-22 2006-02-01 Imp College Innovations Ltd Methods
GB2450840B (en) 2006-05-11 2010-12-29 Quark Pharmaceuticals Inc Screening Systems Utilizing RTP801
WO2007141796A2 (fr) 2006-06-09 2007-12-13 Quark Pharmaceuticals, Inc. Utilisations thérapeutiques d'inhibiteurs de rtp801l
ES2421407T3 (es) * 2007-02-09 2013-09-02 Gene Signal Int Sa Agente y composición para la curación de heridas
EP1980254A1 (fr) * 2007-04-13 2008-10-15 Rijksuniversiteit te Groningen Moyens et procédé de annihilation d'agrégation de protéine
US20100204128A1 (en) * 2007-07-24 2010-08-12 Sanare Investment As Novel peptides
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof
JP2013099253A (ja) * 2010-03-11 2013-05-23 Intec Systems Institute Inc 肺癌または子宮頸癌の診断マーカー
US8288334B2 (en) * 2010-06-14 2012-10-16 Gene Signal International Sa Peptides for wound healing
EP2595646B1 (fr) * 2010-07-21 2015-07-01 Université de Montpellier Proteines bhlh et leur utilisation en tant que medicaments
JP6012605B2 (ja) 2010-09-22 2016-10-25 アリオス バイオファーマ インク． 置換されたヌクレオチドアナログ
US8980865B2 (en) 2011-12-22 2015-03-17 Alios Biopharma, Inc. Substituted nucleotide analogs
US8916538B2 (en) 2012-03-21 2014-12-23 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
EP2827876A4 (fr) 2012-03-22 2015-10-28 Alios Biopharma Inc Combinaisons pharmaceutiques comprenant un analogue thionucléotidique
KR102433282B1 (ko) 2012-08-23 2022-08-16 어젠시스 인코포레이티드 158p1d7 단백질에 결합하는 항체
ES2970246T3 (es) 2015-03-27 2024-05-27 Immatics Biotechnologies Gmbh Péptidos novedosos y combinación de péptidos para usarse en inmunoterapia contra diferentes tumores
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
WO2022216856A1 (fr) * 2021-04-06 2022-10-13 Board Of Regents, The University Of Texas System Méthodes et compositions comprenant des peptides de classe i du cmh

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750345A (en) * 1995-10-31 1998-05-12 Evanston Hospital Corporation Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
WO2001079449A2 (fr) * 2000-04-18 2001-10-25 Hyseq, Inc. Acides nucleiques et polypeptides nouveaux
WO2002081629A2 (fr) * 2001-04-03 2002-10-17 Curagen Corporation Nouvelles proteines humaines, polynucleotides codant celles-ci et procede d'utilisation de ceux-ci

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750345A (en) * 1995-10-31 1998-05-12 Evanston Hospital Corporation Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
WO2001079449A2 (fr) * 2000-04-18 2001-10-25 Hyseq, Inc. Acides nucleiques et polypeptides nouveaux
WO2002081629A2 (fr) * 2001-04-03 2002-10-17 Curagen Corporation Nouvelles proteines humaines, polynucleotides codant celles-ci et procede d'utilisation de ceux-ci

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE Geneseq [online] 18 December 2001 (2001-12-18), "Novel human secreted protein #547.", XP002314713, retrieved from EBI accession no. GSP:AAU30056 Database accession no. AAU30056 *
DATABASE Geneseq [online] 5 February 2003 (2003-02-05), "Human protein NOV20a.", XP002314714, retrieved from EBI accession no. GSP:ABU11055 Database accession no. ABU11055 *
DATABASE UniProt [online] 1 June 2001 (2001-06-01), "Hemoglobin alpha 1 globin chain (Fragment).", XP002314712, retrieved from EBI accession no. UNIPROT:Q9BX83 Database accession no. Q9BX83 *
DATABASE USPTO Proteins [online] 10 December 1998 (1998-12-10), "Sequence 3 from patent US 5750345.", retrieved from EBI accession no. USPOP:AR007678 Database accession no. AR007678 *

Also Published As

Publication number Publication date
EP1430112A2 (fr) 2004-06-23
WO2003029271A3 (fr) 2003-11-20
AU2002343417A1 (en) 2003-04-14
CA2461280A1 (fr) 2003-04-10
WO2003029271A2 (fr) 2003-04-10

Similar Documents

Publication Publication Date Title
EP1504099A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1381621A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1432800A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1470238A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2001234944A8 (en) Novel nucleic acids and polypeptides
EP1325120A4 (fr) Acides nucleiques et polypeptides
EP1430112A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1341804A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2002368010A8 (en) Novel nucleic acids and secreted polypeptides
EP1556490A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
EP1368475A4 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
EP1276751A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2002367815A8 (en) Novel nucleic acids and secreted polypeptides
EP1341803A4 (fr) Nouveaux acides nucleiques et polypeptides
AU2002250419A1 (en) Novel nucleic acids and polypeptides
AU2002365189A8 (en) P85-alpha nucleic acids, polypeptides and related methods
AU2001263005A8 (en) Novel nucleic acids and polypeptides
EP1268762A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1274716A4 (fr) Nouveaux acides nucleiques et nouveaux polypeptides
AU7005801A (en) Gp354 nucleic acids and polypeptides
EP1370675A4 (fr) Nouveaux acides nucleiques et polypeptides
EP1409523A4 (fr) Acides nucleiques et polypeptides pancam

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040322

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050503

17Q First examination report despatched

Effective date: 20050620

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050818